BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, Hameed B, Ganger D, Subramanian RM, Bukofzer S, Ravis WR, Clasen K, Sherker A, Little L, Lee WM; Acute Liver Failure Study Group. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. Hepatology 2018;67:1003-13. [PMID: 29080224 DOI: 10.1002/hep.29621] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Butterworth RF. Hepatic Encephalopathy. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 615-29. [DOI: 10.1002/9781119436812.ch48] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bhatt H, Rao GS. Management of Acute Liver Failure: A Pediatric Perspective. Curr Pediatr Rep 2018;6:246-57. [PMID: 32288972 DOI: 10.1007/s40124-018-0174-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hoilat GJ, Suhail FK, Adhami T, John S. Evidence-based approach to management of hepatic encephalopathy in adults. World J Hepatol 2022; 14(4): 670-681 [DOI: 10.4254/wjh.v14.i4.670] [Reference Citation Analysis]
4 Kerbert AJC, Jalan R. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease. F1000Res 2020;9:F1000 Faculty Rev-312. [PMID: 32399191 DOI: 10.12688/f1000research.22183.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhang H, Zhang W, Yu G, Li F, Hui Y, Cha S, Chen M, Zhu W, Zhang J, Guo G, Gong X. Comprehensive Analysis of lncRNAs, miRNAs and mRNAs in Mouse Hippocampus With Hepatic Encephalopathy. Front Genet 2022;13:868716. [DOI: 10.3389/fgene.2022.868716] [Reference Citation Analysis]
6 Zhang J, Tao B, Chong Y, Ma S, Wu G, Zhu H, Zhao Y, Zhao S, Niu M, Zhang S, Wang T, Yang S, Qiao W, Vuong AM, Li J, Zhu D, Tao W. Ornithine and breast cancer: a matched case-control study. Sci Rep 2020;10:15502. [PMID: 32968187 DOI: 10.1038/s41598-020-72699-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Trovato FM, Rabinowich L, McPhail MJW. Update on the management of acute liver failure. Curr Opin Crit Care 2019;25:157-64. [PMID: 30694840 DOI: 10.1097/MCC.0000000000000583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Olson JC. Intensive Care Management of Patients with Cirrhosis. Curr Treat Options Gastroenterol 2018;16:241-52. [PMID: 29616404 DOI: 10.1007/s11938-018-0182-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Stravitz RT, Lee WM. Acute liver failure. Lancet. 2019;394:869-881. [PMID: 31498101 DOI: 10.1016/s0140-6736(19)31894-x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 54] [Article Influence: 38.0] [Reference Citation Analysis]
10 Fontana RJ, Stravitz RT, Durkalski V, Hanje J, Hameed B, Koch D, Ganger D, Olson J, Liou I, McGuire BM, Clasen K, Lee WM. Prognostic Value of the 13 C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury. Hepatology 2021;74:961-72. [PMID: 33660316 DOI: 10.1002/hep.31783] [Reference Citation Analysis]
11 Liu J, Lkhagva E, Chung HJ, Kim HJ, Hong ST. The Pharmabiotic Approach to Treat Hyperammonemia. Nutrients 2018;10:E140. [PMID: 29382084 DOI: 10.3390/nu10020140] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
12 Han W, Zhang H, Han Y, Duan Z. Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy. Metab Brain Dis. 2020;35:869-881. [PMID: 32495311 DOI: 10.1007/s11011-020-00539-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Treem WR, Palmer M, Lonjon-Domanec I, Seekins D, Dimick-Santos L, Avigan MI, Marcinak JF, Dash A, Regev A, Maller E, Patwardhan M, Lewis JH, Rockey DC, Di Bisceglie AM, Freston JW, Andrade RJ, Chalasani N. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Saf 2021;44:133-65. [PMID: 33141341 DOI: 10.1007/s40264-020-01014-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kornerup LS, Gluud LL, Vilstrup H, Dam G. Update on the Therapeutic Management of Hepatic Encephalopathy. Curr Gastroenterol Rep. 2018;20:21. [PMID: 29644492 DOI: 10.1007/s11894-018-0627-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]